Rep. Robert Bresnahan, Jr. Sells Off Shares of Teleflex Incorporated (NYSE:TFX)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Teleflex Incorporated (NYSE:TFX). In a filing disclosed on March 27th, the Representative disclosed that they had sold between $1,001 and $15,000 in Teleflex stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
• Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.

Teleflex Stock Down 1.2 %

TFX stock traded down $1.61 during trading on Friday, reaching $137.76. 776,408 shares of the stock were exchanged, compared to its average volume of 579,236. The firm has a market cap of $6.39 billion, a P/E ratio of 27.39, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The firm’s 50 day moving average is $159.20 and its 200 day moving average is $190.75. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Analyst Ratings Changes

TFX has been the subject of several research reports. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Wells Fargo & Company dropped their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Truist Financial lowered their price objective on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Hold” and a consensus target price of $182.63.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of TFX. HighTower Advisors LLC increased its holdings in shares of Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after buying an additional 66 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its position in Teleflex by 0.4% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company’s stock valued at $3,614,000 after purchasing an additional 74 shares in the last quarter. Hengehold Capital Management LLC lifted its stake in Teleflex by 7.3% during the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares during the last quarter. Exchange Traded Concepts LLC boosted its holdings in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after purchasing an additional 94 shares in the last quarter. Finally, True Wealth Design LLC raised its holdings in shares of Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock valued at $48,000 after buying an additional 104 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.